tiprankstipranks
Trending News
More News >
NOCIL Limited (IN:NOCIL)
:NOCIL
India Market
Advertisement

NOCIL Limited (NOCIL) AI Stock Analysis

Compare
1 Followers

Top Page

IN:NOCIL

NOCIL Limited

(NOCIL)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 4o)
Rating:63Neutral
Price Target:
₹194.00
▲(7.78% Upside)
NOCIL Limited's overall stock score reflects a company with a strong balance sheet but facing challenges in financial performance and valuation. The technical analysis suggests a neutral to slightly bearish outlook, and the high P/E ratio raises valuation concerns. The absence of earnings call data and corporate events limits additional insights.

NOCIL Limited (NOCIL) vs. iShares MSCI India ETF (INDA)

NOCIL Limited Business Overview & Revenue Model

Company DescriptionNOCIL Limited engages in the manufacture and sale of rubber chemicals for tire and other rubber processing industries in India. The company offers accelerators, anti-degradants, antioxidants, pre vulcanization inhibitors, and post vulcanization stabilizers, as well as solutions that improves thermal stability of cross links in rubber products. It also exports its products. NOCIL Limited was incorporated in 1961 and is headquartered in Mumbai, India.
How the Company Makes MoneyNOCIL Limited generates revenue primarily through the sale of its rubber chemical products. The company's revenue model is based on manufacturing and distributing a diverse range of rubber chemicals that are crucial in the production of tires and other rubber goods. These chemicals are sold domestically within India and exported to international markets, providing a significant source of income. NOCIL's earnings are driven by its strong relationships with key clients in the automotive and industrial sectors, where demand for high-performance rubber products is consistent. Additionally, the company's strategic partnerships with global tire manufacturers and its focus on innovation and sustainability contribute to its revenue streams. Factors such as fluctuations in raw material prices, regulatory changes, and global economic conditions can impact NOCIL's revenue, but its established market presence and continuous product development efforts help maintain its financial stability.

NOCIL Limited Financial Statement Overview

Summary
NOCIL Limited's financial performance is mixed, with a strong balance sheet characterized by minimal leverage and high equity, but challenges in revenue growth and cash flow generation. The income statement shows declining revenue and profit margins, while the cash flow statement highlights liquidity issues with negative free cash flow.
Income Statement
72
Positive
NOCIL Limited has shown a volatile revenue trend over the years with a significant decrease in the latest year. The gross profit margin remains healthy at approximately 42.7% for 2025, but the net profit margin has decreased to 7.4% from 9.3% in 2024. EBITDA margin has also seen a decline. The company needs to address the drop in revenue and profitability margins to enhance its income statement performance.
Balance Sheet
85
Very Positive
The balance sheet of NOCIL Limited indicates strong equity with a high equity ratio of 85.7% in 2025. The debt-to-equity ratio is extremely low at 0.006, suggesting minimal leverage and a conservative capital structure. However, the return on equity has decreased to 5.8% in 2025 from 7.8% in 2024, indicating declining efficiency in generating profits from shareholders' equity.
Cash Flow
60
Neutral
The cash flow position of NOCIL Limited shows a concerning trend with negative free cash flow in recent years. The operating cash flow to net income ratio is very low, suggesting challenges in converting profits into cash. The decline in free cash flow growth rate is a critical area that needs improvement to ensure better liquidity and financial flexibility.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue13.57B13.93B14.37B16.17B15.61B9.13B
Gross Profit5.46B5.95B5.88B7.29B7.02B4.08B
EBITDA1.51B1.37B2.34B2.59B2.89B1.45B
Net Income930.80M1.03B1.33B1.49B1.76B884.10M
Balance Sheet
Total Assets0.0020.57B20.15B18.57B18.30B16.15B
Cash, Cash Equivalents and Short-Term Investments2.73B2.73B3.73B2.30B297.80M1.20B
Total Debt0.00103.00M131.30M97.90M55.20M56.10M
Total Liabilities-17.62B2.95B3.17B3.05B3.85B3.30B
Stockholders Equity17.62B17.62B16.99B15.52B14.45B12.85B
Cash Flow
Free Cash Flow0.00-969.90M1.66B2.52B-664.40M666.10M
Operating Cash Flow0.00255.60M2.01B2.82B-302.20M935.60M
Investing Cash Flow0.00-369.50M-773.60M-2.17B311.60M-621.00M
Financing Cash Flow0.00-502.10M-553.00M-537.70M-336.00M2.70M

NOCIL Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price180.00
Price Trends
50DMA
180.41
Negative
100DMA
184.81
Negative
200DMA
194.66
Negative
Market Momentum
MACD
-1.52
Positive
RSI
49.75
Neutral
STOCH
35.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NOCIL, the sentiment is Neutral. The current price of 180 is below the 20-day moving average (MA) of 181.11, below the 50-day MA of 180.41, and below the 200-day MA of 194.66, indicating a bearish trend. The MACD of -1.52 indicates Positive momentum. The RSI at 49.75 is Neutral, neither overbought nor oversold. The STOCH value of 35.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:NOCIL.

NOCIL Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
₹28.67B27.520.64%-8.66%-17.79%
68
Neutral
₹19.71B3.591.07%2.05%447.29%
67
Neutral
₹35.61B26.350.08%11.77%-1.14%
63
Neutral
₹30.06B32.291.11%-4.47%-26.12%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
55
Neutral
₹41.28B2.81%8.51%84.67%
47
Neutral
₹29.12B0.35%-8.05%-150.62%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:NOCIL
NOCIL Limited
180.00
-90.76
-33.52%
IN:FCL
Fineotex Chemical Limited
250.20
-130.88
-34.34%
IN:GUJALKALI
Gujarat Alkalies & Chemicals Ltd.
562.10
-207.12
-26.93%
IN:INDIANHUME
Indian Hume Pipe Co. Ltd.
374.20
-56.88
-13.19%
IN:ROSSARI
Rossari Biotech Ltd
643.20
-189.77
-22.78%
IN:TIRUMALCHM
Thirumalai Chemicals Limited
284.45
-19.55
-6.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 18, 2025